James W. Crow

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Robyn J. Barst, Lewis J. Rubin, Walker Long et al. · New England Journal of Medicine · 1996 · 2.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 1.4K citations

Medicine, Pharmacology, Pharmacotherapy +11

Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension

Ronald J. Raymond, Alan L. Hinderliter, Park W. Willis et al. · Journal of the American College of Cardiology · 2002 · 823 citations

Medicine, Clinical Sciences, Internal Medicine +16

Effects of Long-term Infusion of Prostacyclin (Epoprostenol) on Echocardiographic Measures of Right Ventricular Structure and Function in Primary Pulmonary Hypertension

Alan L. Hinderliter, Park W. Willis, Robyn J. Barst et al. · Circulation · 1997 · 318 citations

Medicine, Cardiology, Internal Medicine +13

Hemodialysis Using Prostacyclin Instead of Heparin as the Sole Antithrombotic Agent

Randall M. Zusman, Robert H. Rubin, Allen Cato et al. · New England Journal of Medicine · 1981 · 202 citations

Medicine, Hematology, Nephrology +17